Safety & Eff Evals of TM/BP Prod in Repeat Low-Dose Macaque SIV/SHIV Infec Models
$1,087,363Y01FY2010AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
Full title: Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose macaque SIV/SHIV Infection Model To delineate and authorize implementation of a collaboration for preclinical HIV prevention research between the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, and the NIAID.
View original record on NIH RePORTER →